Contemporary Reflections on the Safety of Long-Term Aspirin Treatment for the Secondary Prevention of Cardiovascular Disease

Drug Safety - United Kingdom
doi 10.1007/s40264-016-0421-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Aspirin for Prevention of Cardiovascular Disease

Preventing chronic disease
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Aspirin Dose for the Prevention of Cardiovascular Disease

JAMA - Journal of the American Medical Association
Medicine
2007English

Aspirin for Prevention of Cardiovascular Disease

JAMA - Journal of the American Medical Association
Medicine
2020English

Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes Mellitus

Nature Reviews Endocrinology
EndocrinologyMetabolismDiabetes
2010English

Aspirin for Primary Prevention of Cardiovascular Events

Journal of General Internal Medicine
Internal Medicine
1998English

Omega-6 Fats for the Primary and Secondary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2018English

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

2015English

(Summary of the Recommendations for Long-Term Secondary Prevention After Myocardial Infarction)

Cor et Vasa
Cardiovascular MedicineCardiology
2019English

The Role of mHealth Technology in the Secondary Prevention of Cardiovascular Disease

Romanian Biotechnological Letters
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy